Key result
Intravenous administration of 3 mg/kg risperidone to chronic atrioventricular block dogs prolonged QTcF but did not induce torsade de pointes.
Why the study?
Risperidone potently inhibits IKr as well as alpha1-adrenoceptors, but its torsadogenic action required assessment.
Does risperidone induce torsade de pointes in chronic atrioventricular block model dogs?
Does risperidone induce torsade de pointes in chronic atrioventricular block model dogs?
In a canine model of chronic AV block, a toxic dose of risperidone prolonged QTcF but did not induce torsade de pointes, possibly due to protective reflex sympathetic activation.
Risperidone did not induce torsades despite QT prolongation in this canine model; leaves open the utility of short-term variability as a proarrhythmia predictor.
We assessed torsadogenic action of risperidone, which can potently inhibit IKr as well as α1-adrenoceptor. A toxic dose of 3 mg/kg of risperidone was intravenously administered over 10 min to chronic atrioventricular block dogs without anesthesia with monitoring Holter electrocardiogram (n = 4). Risperidone increased atrial/ventricular rate for 1–12 h/1–6 h and prolonged QTcF at 6 h after its administration, whereas it did not increase short-term variability of repolarization or induced torsade de pointes. These results suggest that α1-adrenoceptor blockade-dependent, hypotension-induced, reflex-mediated increase of sympathetic tone by risperidone might play a role in protecting the heart from IKr inhibition-associated torsade de pointes.
No takes yet. Share an insight, caveat, or question.
Nunoi et al. (2020) studied chronic atrioventricular block (n=4). Risperidone was evaluated on induction of torsade de pointes. Intravenous administration of 3 mg/kg risperidone to chronic atrioventricular block dogs prolonged QTcF but did not induce torsade de pointes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: